Cassava Sciences Inc expected to post a loss of 77 cents a share - Earnings Preview

Filana Therapeutics

03/11/2023 11:06

* Cassava Sciences Inc  SAVA.OQ   SAVA.O  is expected
to show no
change in quarterly revenue when it reports  results 
    * 
    * ​Refinitiv's mean analyst estimate for Cassava Sciences
Inc is
for a loss of 77 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Cassava
Sciences
Inc is $99.5​, above​ its last closing price of $24.24. ​​​

This summary was machine generated November 3 at 11:05 GMT.  All
figures in US dollars  unless otherwise stated